HEC Infra Projects Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 20, 2025, 5:56 pm

Quick Insight

HEC Infra Projects Ltd, a Project Consultancy/Turnkey player, currently trades at a price of 150 with a market capitalization of 162 Cr. With a P/E ratio of 16.8, ROE at 21.0%, and ROCE at 19.0%, the company shows solid returns on equity and capital employed. Operating profit margin stands at 9.32%, indicating efficient cost management. Promoters hold a significant stake at 73.20%, while DIIs and the public own 5.86% and 20.94% respectively. The company's healthy reserves of 42 Cr and manageable borrowings of ₹38 Cr suggest a stable financial position. With a P/BV ratio of 1.98x and interest coverage ratio of 4.72x, HEC Infra Projects appears to be attractively valued and financially sound, making it a potentially promising investment opportunity in the project consultancy industry.

Competitors of HEC Infra Projects Ltd

All Competitor Stocks of HEC Infra Projects Ltd

Quarterly Result

Last Updated: August 1, 2025, 8:20 pm

Below is a detailed analysis of the quarterly data for HEC Infra Projects Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 27.91 Cr.. The value appears to be declining and may need further review. It has decreased from 46.50 Cr. (Mar 2025) to 27.91 Cr., marking a decrease of 18.59 Cr..
• For Expenses, as of Jun 2025, the value is 25.31 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 37.57 Cr. (Mar 2025) to 25.31 Cr., marking a decrease of 12.26 Cr..
• For Operating Profit, as of Jun 2025, the value is 2.60 Cr.. The value appears to be declining and may need further review. It has decreased from 8.93 Cr. (Mar 2025) to 2.60 Cr., marking a decrease of 6.33 Cr..
• For OPM %, as of Jun 2025, the value is 9.32%. The value appears to be declining and may need further review. It has decreased from 19.20% (Mar 2025) to 9.32%, marking a decrease of 9.88%.
• For Other Income, as of Jun 2025, the value is 0.01 Cr.. The value appears strong and on an upward trend. It has increased from -0.13 Cr. (Mar 2025) to 0.01 Cr., marking an increase of 0.14 Cr..
• For Interest, as of Jun 2025, the value is 0.73 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.34 Cr. (Mar 2025) to 0.73 Cr., marking a decrease of 0.61 Cr..
• For Depreciation, as of Jun 2025, the value is 0.14 Cr.. The value appears to be increasing, which may not be favorable. It has increased from -0.10 Cr. (Mar 2025) to 0.14 Cr., marking an increase of 0.24 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.74 Cr.. The value appears to be declining and may need further review. It has decreased from 7.56 Cr. (Mar 2025) to 1.74 Cr., marking a decrease of 5.82 Cr..
• For Tax %, as of Jun 2025, the value is 23.56%. The value appears to be improving (decreasing) as expected. It has decreased from 24.87% (Mar 2025) to 23.56%, marking a decrease of 1.31%.
• For Net Profit, as of Jun 2025, the value is 1.33 Cr.. The value appears to be declining and may need further review. It has decreased from 5.67 Cr. (Mar 2025) to 1.33 Cr., marking a decrease of 4.34 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.23. The value appears to be declining and may need further review. It has decreased from 5.23 (Mar 2025) to 1.23, marking a decrease of 4.00.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:21 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:02 pm

Below is a detailed analysis of the balance sheet data for HEC Infra Projects Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 11.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 42.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Mar 2024) to 42.00 Cr., marking an increase of 17.00 Cr..
• For Borrowings, as of Mar 2025, the value is 38.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 30.00 Cr. (Mar 2024) to 38.00 Cr., marking an increase of 8.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Mar 2024) to 15.00 Cr., marking an increase of 1.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 106.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 79.00 Cr. (Mar 2024) to 106.00 Cr., marking an increase of 27.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 105.00 Cr.. The value appears strong and on an upward trend. It has increased from 78.00 Cr. (Mar 2024) to 105.00 Cr., marking an increase of 27.00 Cr..
• For Total Assets, as of Mar 2025, the value is 106.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2024) to 106.00 Cr., marking an increase of 27.00 Cr..

Notably, the Reserves (42.00 Cr.) exceed the Borrowings (38.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for HEC Infra Projects Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 4.65. This value is below the healthy minimum of 5. It has increased from 0.78 (Mar 23) to 4.65, marking an increase of 3.87.
• For Diluted EPS (Rs.), as of Mar 24, the value is 4.65. This value is below the healthy minimum of 5. It has increased from 0.78 (Mar 23) to 4.65, marking an increase of 3.87.
• For Cash EPS (Rs.), as of Mar 24, the value is 4.82. This value is within the healthy range. It has increased from 0.99 (Mar 23) to 4.82, marking an increase of 3.83.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 34.39. It has increased from 29.73 (Mar 23) to 34.39, marking an increase of 4.66.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 34.39. It has increased from 29.73 (Mar 23) to 34.39, marking an increase of 4.66.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 72.78. It has increased from 51.03 (Mar 23) to 72.78, marking an increase of 21.75.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 8.49. This value is within the healthy range. It has increased from 4.59 (Mar 23) to 8.49, marking an increase of 3.90.
• For PBIT / Share (Rs.), as of Mar 24, the value is 8.32. This value is within the healthy range. It has increased from 4.37 (Mar 23) to 8.32, marking an increase of 3.95.
• For PBT / Share (Rs.), as of Mar 24, the value is 6.53. This value is within the healthy range. It has increased from 1.19 (Mar 23) to 6.53, marking an increase of 5.34.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 4.65. This value is within the healthy range. It has increased from 0.77 (Mar 23) to 4.65, marking an increase of 3.88.
• For PBDIT Margin (%), as of Mar 24, the value is 11.66. This value is within the healthy range. It has increased from 8.98 (Mar 23) to 11.66, marking an increase of 2.68.
• For PBIT Margin (%), as of Mar 24, the value is 11.43. This value is within the healthy range. It has increased from 8.56 (Mar 23) to 11.43, marking an increase of 2.87.
• For PBT Margin (%), as of Mar 24, the value is 8.96. This value is below the healthy minimum of 10. It has increased from 2.32 (Mar 23) to 8.96, marking an increase of 6.64.
• For Net Profit Margin (%), as of Mar 24, the value is 6.39. This value is within the healthy range. It has increased from 1.52 (Mar 23) to 6.39, marking an increase of 4.87.
• For Return on Networth / Equity (%), as of Mar 24, the value is 13.52. This value is below the healthy minimum of 15. It has increased from 2.61 (Mar 23) to 13.52, marking an increase of 10.91.
• For Return on Capital Employeed (%), as of Mar 24, the value is 14.03. This value is within the healthy range. It has increased from 8.58 (Mar 23) to 14.03, marking an increase of 5.45.
• For Return On Assets (%), as of Mar 24, the value is 5.97. This value is within the healthy range. It has increased from 0.92 (Mar 23) to 5.97, marking an increase of 5.05.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.70. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.70.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.86. This value is within the healthy range. It has decreased from 0.97 (Mar 23) to 0.86, marking a decrease of 0.11.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.90. It has increased from 0.62 (Mar 23) to 0.90, marking an increase of 0.28.
• For Current Ratio (X), as of Mar 24, the value is 3.70. This value exceeds the healthy maximum of 3. It has increased from 2.34 (Mar 23) to 3.70, marking an increase of 1.36.
• For Quick Ratio (X), as of Mar 24, the value is 3.16. This value exceeds the healthy maximum of 2. It has increased from 1.86 (Mar 23) to 3.16, marking an increase of 1.30.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 4.72. This value is within the healthy range. It has increased from 1.44 (Mar 23) to 4.72, marking an increase of 3.28.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3.59. This value is within the healthy range. It has increased from 1.24 (Mar 23) to 3.59, marking an increase of 2.35.
• For Enterprise Value (Cr.), as of Mar 24, the value is 87.71. It has increased from 55.94 (Mar 23) to 87.71, marking an increase of 31.77.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.19. This value is within the healthy range. It has increased from 1.08 (Mar 23) to 1.19, marking an increase of 0.11.
• For EV / EBITDA (X), as of Mar 24, the value is 10.19. This value is within the healthy range. It has decreased from 12.03 (Mar 23) to 10.19, marking a decrease of 1.84.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.93. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 23) to 0.93, marking an increase of 0.37.
• For Price / BV (X), as of Mar 24, the value is 1.98. This value is within the healthy range. It has increased from 0.97 (Mar 23) to 1.98, marking an increase of 1.01.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.93. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 23) to 0.93, marking an increase of 0.37.
• For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 23) to 0.06, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness